Ierardi Anna Maria, Kehagias Elias, Piffaretti Gabriele, Piacentino Filippo, De Marchi Giuseppe, Tozzi Matteo, Ioannou Christos, Tonolini Massimo, Magenta Biasina Alberto, Carrafiello Gianpaolo, Tsetis Dimitrios
Unit of Interventional Radiology, Department of Radiology, University of Insubria, 71110, Heraklion, Crete, Greece.
Unit of Interventional Radiology, Department of Radiology, Faculty of Medicine, University Hospital of Heraklion, University of Crete, 71110, Heraklion, Crete, Greece.
Radiol Med. 2016 Jun;121(6):482-93. doi: 10.1007/s11547-016-0623-8. Epub 2016 Feb 16.
We report our experience regarding use of Fluency stent graft (Bard, Murray Hill, NJ, USA) for the treatment of peripheral aneurysms, pseudoaneurysms, arteriovenous fistulae, dissections and arterial ruptures, lacerations or perforations.
This two-center study included 59 patients (40 M, 19 F) with a mean age of 64.37 years (range 20-91 years). In total 61 lesions were treated, so subdivided: 10 true aneurysms, 26 pseudoaneurysms, 5 iatrogenic arteriovenous fistulae, 20 arterial ruptures, lacerations or perforations.
Immediate technical success was obtained in 60 of 61 lesions (98.3 %); in 1 case (pseudoaneurysm of hepatic artery) additional embolization of the gastroduodenal artery with microcoils was needed. Follow-up was available for 57 patients and 59 lesions; mean period was 23.52 months (range 1-60 months). At 1-year primary patency was 89.47 %, whereas secondary patency was 96.4 %.
Endovascular application of Fluency stent graft seems to offer an effective, and durable less invasive alternative to standard surgical techniques for the treatment of peripheral aneurysms, pseudoaneurysms, iatrogenic arteriovenous fistulae and arterial ruptures, or penetrating injuries.
我们报告使用Fluency覆膜支架(美国新泽西州默里山巴德公司)治疗周围动脉瘤、假性动脉瘤、动静脉瘘、夹层以及动脉破裂、撕裂或穿孔的经验。
这项双中心研究纳入了59例患者(男性40例,女性19例),平均年龄64.37岁(范围20 - 91岁)。共治疗61处病变,分类如下:10例真性动脉瘤,26例假性动脉瘤,5例医源性动静脉瘘,20例动脉破裂、撕裂或穿孔。
61处病变中的60处(98.3%)即刻获得技术成功;1例(肝动脉假性动脉瘤)需要用微弹簧圈对胃十二指肠动脉进行额外栓塞。57例患者和59处病变获得随访;平均随访时间为23.52个月(范围1 - 60个月)。1年时的原发性通畅率为89.47%,继发性通畅率为96.4%。
Fluency覆膜支架的血管内应用似乎为治疗周围动脉瘤、假性动脉瘤、医源性动静脉瘘以及动脉破裂或穿透伤提供了一种有效、持久且侵入性较小的替代标准外科技术的方法。